Navigation Links
Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club
Date:11/9/2009

together countries around the globe to consider ways to curb CO2. Light argued that success at the meeting would be an agreement on the architecture--one that will bring developed and undeveloped countries together to work on the issue in a way that ethically accounts for the differing needs and responsibilities of all parties. He went on to call on the United States to take steps to curb CO2 by reducing deforestation, developing renewable energy sources, increasing energy efficiency, and cutting carbon emissions--steps which Light projected would save the United States a net of 14 billion dollars.

Jonathan Moreno, Ph.D., is a senior fellow at the Center for American Progress, a David and Lyn Silfen University professor of ethics, a professor of medical ethics and of history and sociology of science at the University of Pennsylvania and formerly a member of President Barack Obama's transition team for the Department of Health and Human Services. Andrew Light, Ph.D., is a senior fellow at the Center for American Progress and director of the Center for Global Ethics at George Mason University. The panel was moderated by Ana Lita, Ph.D., the director of the Appignani Bioethics Center at the United Nations in New York City.

The Appignani Bioethics Center (ABC), a project of the American Humanist Association, helps inform local, state, national and international policy debates about global issues in medical and biotechnological sciences through collaboration with NGOs and UN departments, bodies and agencies. The Center provides educational venues and opportunities for confronting various issues facing developed and developing world countries. www.humanistbioethics.org.

The American Humanist Association (www.americanhumanist.org) advocates for the rights and viewpoints of humanists. Founded in 1941 and headquartered in Washington, D
'/>"/>

SOURCE American Humanist Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors
2. Guillermo Moreno Named Aurillions Vice President of Sales and Marketing
3. Vical Names Andrew de Guttadauro Vice President, Corporate Development
4. MacAndrews & Forbes Names Barry F. Schwartz as Executive Vice Chairman
5. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
6. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
7. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
8. Algeta Appoints Andrew Kay as President and Chief Executive Officer
9. Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics
10. Veridiam Appoints Andrew Gale as Chief Executive Officer
11. BioNeutral Groups CEO, Stephen Browand and Chief Scientist, Dr. Andrew Kielbania to Appear on WVOX 1460 AM In Focus Radio Show Hosted by Dr. Dan Miller
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... LA JOLLA, Calif. , July 29, 2014 /PRNewswire/ ... therapy-based diagnostic and therapeutic company focused on extending the ... have hired Franz Och , Ph.D., an expert ... Chief Data Scientist. Och comes to HLI from Google ... of Google Translate. He will report directly to HLI ...
(Date:7/29/2014)... CITY, Md. , July 29, 2014 /PRNewswire/ ... announced a new and updated program for the ... 10 – 12, 2014 in Amelia Island ... CROs, sites and investigators remains unchanged, however, the ... purposeful exchange and networking opportunity among all stakeholders ...
(Date:7/29/2014)... , July 29, 2014  Discovery Laboratories, Inc. ... advancing a new standard of respiratory critical care, will ... August 5, 2014 before the open of the ... will host a live teleconference and webcast at ... conference call, Discovery Labs, management will discuss the ...
(Date:7/29/2014)... July 29, 2014  ImmunoClin Corporation (IMCL) is ... treatment of infectious diseases as well as nutraceuticals. ... prevention of pathologies like cardiovascular disease, Alzheimer,s disease ... ImmunoClin Corporation will complete the strategic relocation of ... , a key center of North American ...
Breaking Biology Technology:Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist 2Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist 3TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 2TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 3Discovery Labs to Report 2014 Second Quarter Financial Results and Hold Conference Call on Tuesday, August 5, 2014 at 9:00 a.m. Eastern Time 2ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 2ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 3
... Inc. (OTC Bulletin Board: TBIO). In a peer-reviewed ... journal Human Mutation, a team at Weill Cornell Medical ... of using Transgenomic,s Surveyor Nuclease technology for mutation scanning ... important genes used in the diagnosis and prognosis of ...
... address individual lifestyle needsDALLAS, April 2 ... largest manufacturers of hearing instruments in the world, today ... Academy of Audiology,s 21st Annual AudiologyNOW! Conference held April ... product models in the Motion(TM) line and their expanded ...
... 2 Shire plc (LSE: SHP,NASDAQ: SHPGY ... the U.S. District,Court for the Southern District of New ... of Shire,s patents: U.S. Patent No.,5,968,976 (",976 Patent"); and ... The lawsuit was filed in response to ...
Cached Biology Technology:Polycystic Kidney Disease Assay at Cornell University Uses Transgenomic's Surveyor Nuclease & WAVE Technology 2Polycystic Kidney Disease Assay at Cornell University Uses Transgenomic's Surveyor Nuclease & WAVE Technology 3Polycystic Kidney Disease Assay at Cornell University Uses Transgenomic's Surveyor Nuclease & WAVE Technology 4Siemens Showcases New Hearing Loss Solutions at AudiologyNOW! Conference 2Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL(R) (lanthanum carbonate) Patents 2
(Date:7/29/2014)... of cell, including sperm, bacteria and algae, propel ... protrusions, about one-hundredth of a millimetre long, function ... Similar, shorter structures called cilia are found on ... roles such as moving liquids over the cell. ... they transport mucus and expel pathogens from our ...
(Date:7/28/2014)... the University of Arizona has sequenced the complete genome ... scientists, and agriculturalists, understanding of the growing patterns of ... new rice varieties that are better able to cope ... challenges. , The paper, "The genome sequence of African ... domestication," was published online in Nature Genetics ...
(Date:7/28/2014)... suggests that the effects of a commonly used anesthetic ... , The study, published in this week,s issue of ... biologists at the University of California, San Diego and ... to concerns, arising from multiple studies on humans over ... may increase their susceptibility to long-term cognitive and behavioral ...
Breaking Biology News(10 mins):Microscopic rowing -- without a cox 2Microscopic rowing -- without a cox 3Generating a genome to feed the world: UA-led team sequences African rice 2Generating a genome to feed the world: UA-led team sequences African rice 3Generating a genome to feed the world: UA-led team sequences African rice 4Study suggests disruptive effects of anesthesia on brain cell connections are temporary 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 3
... are showing promise against neuroAIDS, the nerve damage caused ... think and move. As evidence of the progress, researchers ... a $7 million grant to confirm that two new ... damage. Driving their approach is the realization that antiviral ...
... drug development for killer diseases such as HIV/AIDS, TB, ... years. This is despite the fact that these diseases ... of treatments is inhibitive due to lack of economic ... drugs (and of some vaccines and diagnostics) would increase ...
... which means that they must be continually replaced by ... cell types needed by the body. Claus Nerlov ... (EMBL) unit in Monterotondo, Italy, in collaboration with researchers ... Lund in Sweden, have now uncovered how an intracellular ...
Cached Biology News:Researchers seek to design first treatment for neuroAIDS 2Researchers seek to design first treatment for neuroAIDS 3Researchers seek to design first treatment for neuroAIDS 4Increase in drug development for killer diseases is not enough 2Lost in the labyrinth 2
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Rabbit polyclonal to Leucyl tRNA synthetase ( Abpromise for all tested applications). Antigen: L930-H1176 denatured human recombinant LRS. Entrez Gene ID: 3926 Swiss Protein ID: Q9P2J5...
WNV Core Antibody...
Mouse monoclonal [YPF19] to Yersinia pestis ( Abpromise for all tested applications)....
Biology Products: